Integrum AB Series B (INTEG-B) - Total Liabilities

Latest as of June 2026: Skr24.96 Million SEK ≈ $2.69 Million USD

Based on the latest financial reports, Integrum AB Series B (INTEG-B) has total liabilities worth Skr24.96 Million SEK (≈ $2.69 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See INTEG-B working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Integrum AB Series B - Total Liabilities Trend (2013–2025)

This chart illustrates how Integrum AB Series B's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Integrum AB Series B.

Integrum AB Series B Competitors by Total Liabilities

The table below lists competitors of Integrum AB Series B ranked by their total liabilities.

Company	Country	Total Liabilities
N.D. Rubber Public Company Limited BK:NDR	Thailand	฿279.69 Million
Essen Tech Co. Ltd KQ:043340	Korea	₩43.71 Billion
Tobii AB ST:TOBII	Sweden	Skr840.00 Million
Renovaro Biosciences Inc NASDAQ:RENB	USA	$29.58 Million
Ravinder Heights Limited NSE:RVHL	India	Rs348.26 Million
Thai O.P.P. Public Company Limited BK:TOPP	Thailand	฿350.88 Million
Kisan Telecom Co. Ltd KQ:035460	Korea	₩68.24 Billion
Murray International Trust LSE:MYI	UK	GBX112.39 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Integrum AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Integrum AB Series B to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.33	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.14	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.13	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Integrum AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Integrum AB Series B (2013–2025)

The table below shows the annual total liabilities of Integrum AB Series B from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr31.59 Million ≈ $3.40 Million	+24.48%
2024-12-31	Skr25.38 Million ≈ $2.73 Million	+14.98%
2023-12-31	Skr22.07 Million ≈ $2.38 Million	+2.01%
2022-12-31	Skr21.64 Million ≈ $2.33 Million	+4.55%
2021-12-31	Skr20.70 Million ≈ $2.23 Million	+60.25%
2020-12-31	Skr12.91 Million ≈ $1.39 Million	+52.49%
2019-12-31	Skr8.47 Million ≈ $911.38K	-4.33%
2018-12-31	Skr8.85 Million ≈ $952.60K	+5.65%
2017-12-31	Skr8.38 Million ≈ $901.62K	-9.31%
2016-12-31	Skr9.24 Million ≈ $994.23K	+2.27%
2015-12-31	Skr9.03 Million ≈ $972.20K	+71.03%
2014-12-31	Skr5.28 Million ≈ $568.43K	-5.99%
2013-12-31	Skr5.62 Million ≈ $604.66K	--

About Integrum AB Series B

ST:INTEG-B Sweden Medical Devices

Market Cap

$26.19 Million

Skr243.36 Million SEK

Market Cap Rank

#24318 Global

#466 in Sweden

Share Price

Skr9.35

Change (1 day)

+0.32%

52-Week Range

Skr6.96 - Skr15.64

All Time High

Skr102.00